ABSTRACT
Artificial intelligence (AI) shape the business enterprises and enable in realizing enhanced growth and development. It has been observed that the application of AI enables in influencing the organizational culture in an effective manner thereby enhancing the working environment which will lead to better productivity and output. The implementation of AI support in enhancing the entrepreneurial aspects through enhancing the cultural and ethical aspects and influence better decision making, create new business practices which will harness human capital and effective leadership capabilities. It has been regarded that the implementation of AI possesses the overall ability to quickly understand the business process and address the issues efficiently for superior performance. The companies which apply AI enable in enhancing the service delivery, understand customer requirements, forecast the business patterns for realizing growth and development. It has been regarded that the current organizational environment is focusing in implementing effective and dynamic capabilities which will influence in attaining growth and success in an effective manner Therefore, the overall success to these initiatives is mainly based on the changes in the internal and external environment, and culture & ethical aspects are being applied in the organizational context. The application of effective leadership support in enhancing the organizational culture and which will create better entrepreneurial aspect for effective performance. This study is focused in addressing the critical strategic evaluation of implementing Artificial Intelligence towards shaping Entrepreneurial Development during COVID- 19 Outbreaks. In its pure essence it is focused in understanding the critical nature of culture and ethical aspect which will enable in creating better programs and support entrepreneurial spirit. © 2022 IEEE.
ABSTRACT
This article has been withdrawn at the request of the editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
ABSTRACT
BACKGROUND: COVID-19 pandemic has taken a great toll on the health care system worldwide. Along with the pandemic, there is also a concern regarding post COVID-19 complications in recovered patients. Thromboembolism (TE) has been reported as a fatal complication in recovered patients with COVID-19. There is still a great dilemma in post-discharge TE prophylaxis and its long-term benefits. CASE DESCRIPTION: We reported three cases of post COVID-19 with complications related to both diseases as well as post discharge anticoagulant therapy. The first case is about a 60-yr-old male who developed Covid-19 pneumonia (moderate disease) and was discharged on rivaroxaban after initial improvement. 3 weeks later, the patient was readmitted with lower gastro-intestinal bleeding. The other two cases developed pulmonary thromboembolism within a span of 2-3 months (after recovered from COVID-19 pneumonia). Both these patients were not prescribed anticoagulants for TE prophylaxis. CONCLUSION: There is an imperative need for effective guidelines for post discharge TE prophylaxis in COVID-19.